Presentation on theme: "HL7-Individual Case Safety Reporting (ICSR)"— Presentation transcript:
1 HL7-Individual Case Safety Reporting (ICSR) Terminology Challenges
2 Current model encompasses reporting of drug, device and vaccines related case safety reporting capabilitiesModel build upon ICH’s E2B SpecificationsCurrently incorporating FDA and CDC’s adverse event reporting form contents: MedWatch (drug and devices adverse event reporting) and VAERS (vaccine adverse event reporting).
3 Future domains involved - Blood Products Deviations ReportingNosocomial Infection ReportingRequirements from National Patient Safety Agency, UKFood SupplementsVeterinary Products, etc.
4 Where will the uses be?Messaging will be used in several different scenarioswithin hospital systems,hospital/provider to state/local government,hospital/provider to US Federal Agencies,hospital/provider to manufacturers,hospital/provider to stakeholder agencies (NPSA, UK), andother
5 Future work will also involve- Taxonomy for Medical Errors, including near missTaxonomy of healthcare processes to answer the questions about where in the healthcare process did events and contributory factors occur.
Your consent to our cookies if you continue to use this website.